PREVALENCE, MORTALITY FROM COVID-19, AND VACCINATION COVERAGE FOR NEW CORONAVIRUS INFECTION IN THE DRUG DISORDER GROUP
The article is devoted to the assessment of the prevalence of vaccination coverage against COVID-19, morbidity and mortality from a new coronavirus infection among persons suffering from drug diseases in the Samara region. It was established that vaccination from COVID-19 in the year 2021 covered 33.4% (95% CI: 32.8 - 34.0) people suffering from drug diseases, while coronavirus infection was identified in 6.4% (95% CI: 6.1 - 6.7) drug patients, mortality from COVID-19 was 0.19% (95% CI: 0.15 - 0.22). The largest proportion of vaccinated patients was registered in the tobacco (71.8%) and alcohol user group (35.5%), the smallest - in the stimulant user group (23.8%). The largest proportion of those who had COVID-19 and died from it was recorded in the group of tobacco (12.8% and 0%), opiate users (7.3% and 0.28%) and the group of users of several narcotic substances (6.5% and 0.3%).